Olympus Corporation (OLYMY)
OTCMKTS
· Delayed Price · Currency is USD
13.03
-0.06 (-0.46%)
May 15, 2025, 9:30 AM EDT
Olympus Revenue
In the fiscal year ending March 31, 2025, Olympus had annual revenue of 997.33B JPY with 6.53% growth. Olympus had revenue of 272.11B in the quarter ending March 31, 2025, with 4.46% growth.
Revenue
997.33B JPY
Revenue Growth
+6.53%
P/S Ratio
2.17
Revenue / Employee
34.58M JPY
Employees
28,838
Market Cap
14.46B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 997.33B | 61.12B | 6.53% |
Mar 31, 2024 | 936.21B | 54.29B | 6.16% |
Mar 31, 2023 | 881.92B | 13.06B | 1.50% |
Mar 31, 2022 | 868.87B | 138.32B | 18.93% |
Mar 31, 2021 | 730.54B | -66.87B | -8.39% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
Silence Therapeutics | 27.70M |